Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: May 18, 2026
TU + NET-EN

Testosterone Undecanoate (TU) + Norethisterone Enanthate (NET-EN)

Inactive
Last updated: May 18, 2026
Nutlin-3a
Inactive
Last updated: May 18, 2026
Quinacrine Pellets

Quinacrine Sterilization (QS)

Inactive
Last updated: May 18, 2026
Gossypol
Inactive
Last updated: May 18, 2026
Selective Androgen Receptor Modulators (SARMs)

SARM C-6, GTx C-6

Inactive
Last updated: May 18, 2026
Zeolite Nanoparticle Vaginal Gel
Inactive
Last updated: May 18, 2026
Onapristone

ZK 98 299

Inactive
Last updated: May 7, 2026
Ulipristal Acetate Vaginal Ring + Oral LNG
Inactive
Last updated: May 7, 2026
Monthly Mifepristone